Genomic structure and nucleotide sequence analysis of a new HIV type 1 subtype A strain from Nigeria

AIDS Research and Human Retroviruses

Volumn 12, Issue 15, 1996, Pages 1413-1425

  Howard, Thomas M ^a   Rasheed, Suraiya ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REV PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CYTOPATHOGENIC EFFECT; DNA RESPONSIVE ELEMENT; ENVELOPE GENE; FRAMESHIFT MUTATION; GENE INSERTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONONUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOP CODON; VIRUS GENOME;

EID: 0029846734     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1413     Document Type: Article

References (62)

1. Olaleye DO, Sheng Z, Howard TM, and Rasheed S: Isolation and characterization of a new subtype A variant of human immunodeficiency virus type 1 from Nigeria. Trop Med Int Health 1996;1:97-106.
2. Myers G, Korber B, Hahn BH, Jeang K-T, Mellors JW, McCutchan FE, Henderson LE, and Pavlakis GN (eds.): Human Retroviruses and AIDS 1995. Los Alamos National Laboratory, Los Alamos, New Mexico, 1995.
3. Myers G, Korber B, Wain-Hobson S, Jeang K-T, Henderson LE, and Pavlakis GN (eds.): Human Retroviruses and AIDS 1994. Los Alamos National Laboratory, Los Alamos, New Mexico, 1994.
4. Charneau P, Borman AM, Quillent C, Guetard D, Chamaret S, Cohen J, Remy G, Montagnier L, and Clavel F: Isolation and envelope sequence of a highly divergent HIV-1 isolate: Definition of a new HIV-1 group. Virology 1994;205:247-253.
5. Myers G: HIV: Between past and future. AIDS Res Hum Retroviruses 1994;10:1317-1322.
6. De Leys R, Vanderborght B, Vanden Haesevelde M, Heyndrickx L, van Geel A, Wauters C, Bernaerts R, Saman E, Nijs P, Willems B, Taelman H, van der Groen G, Piot P, Tersmette T, Huisman JG, and Van Heuverswyn H: Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin. J Virol 1990; 64:1207-1216.
7. Gürtler LG, Hauser PH, Eberle J, von Brunn A, Knapp S, Zekeng L, Tsague JM, and Kaptue L: A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol 1994;68:1581-1585.
8. Vanden Haesevelde M, Decourt J-L, De LRJ, Vanderborght B, van der Groen G, van Heuverswijn H, and Saman E: Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J Virol 1994;68:1586-1596.
9. Loussert-Ajaka I, Chaix M-L, Korber B, Letourneur F, Gomas E, Allen E, Ly T-D, Brun-Vézinet F, Simon F, and Saragosti S: Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J Virol 1995;69:5640-5649.
10. Anonymous: GPA raises infection estimates. Global AIDS News 1993;3:16.
11. Olaleye O, Bernstein L, Ekweozor C, Zhijuan S, Omilabu S, Li X, Sullivan-Halley J, and Rasheed S: Prevalence of human immunodeficiency virus types 1 and 2 infections in Nigeria. J Infect Dis 1993;167:710-714.
12. Howard TM, Olaleye DO, and Rasheed S: Sequence analysis of the glycoprotein 120 coding region of a new HIV type 1 subtype A strain (HIV-1IbNg) from Nigeria. AIDS Res Hum Retroviruses 1994;10:1755-1757.
13. Abimiku AG, Stern TL, Zwandor A, Markham PD, Calef C, Kyari S, Saxinger WC, Gallo RC, Robert-Guroff M, and Reitz MS: Subgroup G HIV-1 type 1 isolates from Nigeria. AIDS Res Hum Retroviruses 1994;10:1581-1583.
14. Oram JD, Downing RG, Roff M, Clegg JC, Serwadda D, and Carswell JW: Nucleotide sequence of a Ugandan HIV-1 provirus reveals genetic diversity from other HIV-1 isolates. AIDS Res Hum Retroviruses 1990;6:1073-1078.
15. Staden R: A new computer method for the storage and manipulation of DNA gel reading data. Nucleic Acids Res 1980;8:3673-3694.
16. Feng DF and Doolittle RF: Progressive sequence alignment as a prerequisite to correct phylogenetic trees. J Mol Evol 1987;25:351-360.
17. Felsenstein J: PHYLIP - Phytogeny inference package. Cladistics 1989;5:164-166.
18. Gibbs JS and Desrosiers RC: Auxiliary proteins of the primate immunodeficiency viruses. In: Human Retroviruses (Cullen BR, ed.). IRL Press, Oxford, 1993, pp. 137-158.
19. 17b. Ou CY, Kwok S, Mitchell SW, Mack DH, Sninsky JJ, Krebs JW, Feorino P, Warfield D, and Schochetman G: DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 1988;239:295-297.
20. Lenardo MJ and Baltimore D: NF-kappa B: A pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989;58:227-229.
21. Jones KA, Kadonaga JT, Luciw PA, and Tjian R: Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 1986;232:755-759.
22. Jakobovits A, Smith DH, Jakobovits EB, and Capon DJ: A discrete element 3′ of human immunodeficiency virus 1 (HIV-1) and HIV-1 mRNA initiation sites mediates transcriptional activation by an HIV trans activator. Mol Cell Biol 1988;8:2555-2561.
23. Lever A, Gottlinger H, Haseltine W, and Sodroski J: Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J Virol 1989; 63:4085-1087.
24. Gorelick RJ and Henderson LE: Gag proteins. In: Human Retroviruses and AIDS 1994 (Myers G, Korber B, Wain-Hobson S, Jeang K-T, Henderson LE, and Pavlakis GN, eds.). Los Alamos National Laboratory, Los Alamos, New Mexico, 1994, III-2-III-8.
25. Luban J, Alin KB, Bossolt KL, Humaran T, and Goff SP: Genetic assay for multimerization of retroviral Gag polyproteins. J Virol 1992;66:5157-5160.
26. Mammano F, Ohagen A, Hoglund S, and Gottlinger HG: Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J Virol 1994;68:4927-4936.
27. Berg JM: Potential metal-binding domains in nucleic acid binding proteins. Science 1986;232:485-487.
28. Huang M, Orenstein JM, Martin MA, and Freed EO: p6gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol 1995;69:6810-6818.
29. gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles. J Virol 1995;69:6873-6879.
30. Delarue M, Poch O, Tordo N, Moras D, and Argos P: An attempt to unify the structure of polymerases. Protein Eng 1990; 3:461-467.
31. Doolittle RF, Feng DF, Johnson MS, and McClure MA: Origins and evolutionary relationships of retroviruses. Q Rev Biol 1989; 64:1-30.
32. Vincent KA, Ellison V, Chow SA, and Brown PO: Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations. J Virol 1993;67:425-437.
33. Zapp ML, Hope TJ, Parslow TG, and Green MR: Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: A dual function for an arginine-rich binding motif. Proc Natl Acad Sci USA 1991;88:7734-7738.
34. Cochrane AW, Perkins A, and Rosen CA: Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: Relevance of nucleolar localization to function. J Virol 1990;64:881-885.
35. Olsen HS, Beidas S, Dillon P, Rosen CA, and Cochrane AW: Mutational analysis of the HIV-1 Rev protein and its target sequence, the Rev responsive element. J Acquir Immune Defic Syndr 1991;4:558-567.
36. Goncalves J, Shi B, Yang X, and Gabuzda D: Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains. J Virol 1995;69: 7196-7204.
37. Sakai H, Shibata R, Sakuragi J-I, Sakuragi S, Kawamura M, and Adachi A: Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J Virol 1993;67:1663-1666.
38. Yao X-J, Subramanian RA, Rougau N, Boisvert F, Bergeron D, and Cohen EA: Mutagenic analysis of human immunodeficiency virus type 1 Vpr: Role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J Virol 1995;69:7032-7044.
39. Yu H, Chen JK, Feng S, Dalgarno DC, Brauer AW, and Schreiber SL: Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 1994;76:933-945.
40. Piatak MJ, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM, and Lifson JD: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-1754.
41. Rasheed S, Li Z, and Xu D: Human immunodeficiency virus load. Quantitative assessment in semen from seropositive individuals and in spiked seminal plasma. J Reprod Med 1995;40:747-757.
42. Robertson DL, Hahn BH, and Sharp PM: Recombination in AIDS viruses. J Mol Evol 1995;40:249-259.
43. Jiang M, Mak J, Ladha A, Cohen E, Klein M, Rovinski B, and Kleiman L: Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1. J Virol 1993;67:3246-3253.
44. Aiyar A, Cobrinik D, Ge Z, Kung HJ, and Leis J: Interaction between retroviral U5 RNA and the T psi C loop of the tRNA(Trp) is required for efficient initiation of reverse transcription. J Virol 1992;66:2464-2472.
45. Kohlstaedt LA and Steitz TA: Reverse transcriptase of human immunodeficiency virus can use either human tRNALys3 or Escherichia coli tRNAGln2 as a primer in an in vitro primer-utilization assay. Proc Natl Acad Sci USA 1992;89:9652-9656.
46. Jacks T, Madhani HD, Masiarz FR, and Varmus HE: Signals for ribosomal frameshifting in the Rous sarcoma virus gag-pol region. Cell 1988;55:447-458.
47. Carroll R, Martarano L, and Derse D: Identification of lentivirus Tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras. J Virol 1991;65:3460-3467.
48. Derse D, Carvalho M, Carroll R, and Peterlin BM: A minimal lentivirus Tat. J Virol 1991;65:7012-7015.
49. Dingwall C, Ernberg I, Gait MJ, Green SM, Heaphy S, Karn J, Lowe AD, Singh M, Skinner MA, and Valerio R: Human immunodeficiency virus 1 Tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci USA 1989;86:6925-6929.
50. Weeks KM and Crothers DM: RNA recognition by Tat-derived peptides: Interaction in the major groove? Cell 1991;66:577-588.
51. Hauber J, Malim MH, and Cullen BR: Mutational analysis of the conserved basic domain of human immunodeficiency virus Tat protein. J Virol 1989;63:1181-1187.
52. Ruben S, Perkins A, Purcell R, Joung K, Sia R, Burghoff R, Haseltine WA, and Rosen CA: Structural and functional characterization of human immunodeficiency virus Tat protein. J Virol 1989;63:1-8.
53. Jeang KT and Gatignol A: Comparison of regulatory features among primate lentiviruses. In: Simian Immunodeficiency Virus (Letvin NL and Desrosiers RC, eds.). Springer-Verlag, Berlin, 1994, pp. 123-144.
54. Myers G, Korber B, Berzofsky J, Smith R, and Pavlakis G (eds.): Human Retroviruses and AIDS 1992. Los Alamos National Laboratory, Los Alamos, New Mexico, 1992.
55. Myers G, Korber B, Wain-Hobson S, Smith R, and Pavlakis G (eds.): Human Retroviruses and AIDS 1993. Los Alamos National Laboratory, Los Alamos, New Mexico, 1993.
56. Malim MH, Bohnlein S, Hauber J, and Cullen BR: Functional dissection of the HIV-1 Rev trans-activator - Derivation of a trans-dominant repressor of Rev function. Cell 1989; 58:205-214.
57. Mermer B, Felber BK, Campbell M, and Pavlakis GN: Identification of trans-dominant HIV-1 Rev protein mutants by direct transfer of bacterially produced proteins into human cells. Nucleic Acids Res 1990;18:2037-2044.
58. Benjouad A, Gluckman JC, Rochat H, Montagnier L, and Bahraoui E: Influence of carbohydrate moieites on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160. J Virol 1992;66:2473-2483.
59. Bosch ML, Andeweg AC, Schipper R, and Kenter M: Insertion of N-linked glycosylation sites in the variable regions of the human immunodeficiency virus type 1 surface glycoprotein through AAT triplet reiteration. J Virol 1994;68:7566-7569.
60. Li Y, Luo L, Rasool N, and Kang CY: Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. J Virol 1993;67:584-588.
61. Lee WR, Syu WJ, Du B, Matsuda M, Tan S, Wolf A, Essex M, and Lee TH: Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1992;89:2213-2217.
62. Levy JA: HIV and the Pathogenesis of AIDS. American Society for Microbiology, Washington, D.C., 1994, p. 94.